PT2626420T - Polipéptidos que codificam epítopos de terth restritos à molécula hla-b7 da classe i do cph, os seus análogos ou poliepítopos - Google Patents

Polipéptidos que codificam epítopos de terth restritos à molécula hla-b7 da classe i do cph, os seus análogos ou poliepítopos

Info

Publication number
PT2626420T
PT2626420T PT131658544T PT13165854T PT2626420T PT 2626420 T PT2626420 T PT 2626420T PT 131658544 T PT131658544 T PT 131658544T PT 13165854 T PT13165854 T PT 13165854T PT 2626420 T PT2626420 T PT 2626420T
Authority
PT
Portugal
Prior art keywords
polyepitopes
hla
analogues
mhc class
polynucleotides encoding
Prior art date
Application number
PT131658544T
Other languages
English (en)
Inventor
Langlade-Demoyen Pierre
Garcia Pons Fransisco
Adotevi Olivier
Cardinaud Sylvain
Neuveut Christine
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Publication of PT2626420T publication Critical patent/PT2626420T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT131658544T 2005-07-29 2006-07-31 Polipéptidos que codificam epítopos de terth restritos à molécula hla-b7 da classe i do cph, os seus análogos ou poliepítopos PT2626420T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05291627A EP1748067A1 (en) 2005-07-29 2005-07-29 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes

Publications (1)

Publication Number Publication Date
PT2626420T true PT2626420T (pt) 2016-09-28

Family

ID=35735256

Family Applications (1)

Application Number Title Priority Date Filing Date
PT131658544T PT2626420T (pt) 2005-07-29 2006-07-31 Polipéptidos que codificam epítopos de terth restritos à molécula hla-b7 da classe i do cph, os seus análogos ou poliepítopos

Country Status (9)

Country Link
US (3) US8858931B2 (pt)
EP (3) EP1748067A1 (pt)
JP (4) JP5631545B2 (pt)
CA (1) CA2616674C (pt)
DK (2) DK1910529T3 (pt)
ES (2) ES2590462T3 (pt)
PL (1) PL2626420T3 (pt)
PT (1) PT2626420T (pt)
WO (1) WO2007014740A2 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10767167B2 (en) 2005-07-29 2020-09-08 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
EP1748067A1 (en) * 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
WO2008010010A1 (en) 2006-07-12 2008-01-24 Vaxon Biotech Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
US20080171062A1 (en) * 2006-08-16 2008-07-17 Monica Sala-Schaeffer Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use
JP5596980B2 (ja) * 2007-02-28 2014-10-01 アメリカ合衆国 ブラキュリポリペプチドおよび使用方法
NZ582822A (en) * 2007-07-27 2012-06-29 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
US7904566B2 (en) * 2008-03-14 2011-03-08 Silicon Image, Inc. Method, apparatus, and system for employing an enhanced port multiplier
US7979589B2 (en) * 2008-03-14 2011-07-12 Silicon Image, Inc. Method, apparatus, and system for port multiplier enhancement
CN102858964B (zh) 2010-02-16 2018-10-02 阿尔特公司 多肽
RU2014140792A (ru) 2012-03-15 2016-05-10 Макрокьюэ, Лтд. Активированная иммуностимулирующая клеточная композиция и ее использование
WO2013136191A1 (en) 2012-03-15 2013-09-19 Macrocure, Ltd. Activated immunostimulatory cell composition for therapy of infection
EP2639299A1 (en) 2012-03-16 2013-09-18 Invectys Universal cancer peptides derived from telomerase
US9453209B2 (en) 2012-12-27 2016-09-27 Sierra Sciences, Llc Enhancing health in mammals using telomerase reverse transcriptase gene therapy
DK2978445T3 (en) * 2013-03-28 2018-10-15 Invectys A CANCERVACCINE FOR CAT
DK2978444T3 (en) * 2013-03-28 2019-03-18 Invectys CANCERVACCINE FOR DOGS
GB201315946D0 (en) * 2013-09-06 2013-10-23 Immune Targeting Systems Its Ltd Oncology vaccine
HUE047898T2 (hu) * 2013-10-28 2020-05-28 Invectys Telomerázt kódoló DNS vakcina
AU2014343808B2 (en) 2013-10-28 2020-03-05 Centre National De La Recherche Scientifique Gene electrotransfer into skin cells
JP7152156B2 (ja) 2015-01-14 2022-10-12 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド 抗ｌａｐモノクローナル抗体による癌の処置
CA2979388A1 (en) 2015-03-12 2016-09-15 Health Research, Inc. Enrichment of cd16+ monocytes to improve dendritic cell vaccine quality
WO2016168601A1 (en) 2015-04-17 2016-10-20 Khalid Shah Agents, systems and methods for treating cancer
US20180251781A1 (en) * 2015-10-06 2018-09-06 Invectys Polyepitope constructs for use in immunotherapy
GB201519557D0 (en) 2015-11-05 2015-12-23 Univ Witwatersrand Jhb Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
SI3405212T1 (sl) 2016-01-19 2020-09-30 Pfizer Inc. Cepiva proti raku
AU2017336088B2 (en) * 2016-09-30 2023-07-06 Inovio Pharmaceuticals, Inc. Tert immunogenic compositions and methods of treatment using the same
EP3622078A1 (en) 2017-05-09 2020-03-18 Invectys Recombinant measles vaccine expressing htert
AU2018395397A1 (en) * 2017-12-28 2020-08-06 Gritstone Bio, Inc. Antigen-binding proteins targeting shared antigens
CN110305217B (zh) 2018-03-27 2022-03-29 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用
WO2019197610A1 (en) 2018-04-13 2019-10-17 INSERM (Institut National de la Santé et de la Recherche Médicale) New vaccinal strategy
CN113105528B (zh) * 2020-01-13 2023-12-08 辽宁中健医药科技有限公司 一条肿瘤相关抗原ctl表位肽及其应用
AU2021294322A1 (en) * 2020-06-26 2023-02-02 National Breast Cancer Coalition Breast cancer vaccine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129103A0 (en) * 1996-10-01 2000-02-17 Geron Corp Human telomerase catalytic subunit and pharmaceutical compositions containing same
US7622549B2 (en) * 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) * 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
AU748442B2 (en) * 1997-07-01 2002-06-06 Cambia Vertebrate telomerase genes and proteins and uses thereof
CA2347067C (en) * 1998-03-31 2013-09-17 Geron Corporation Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
FR2777909B1 (fr) 1998-04-24 2002-08-02 Pasteur Institut Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
US7030211B1 (en) * 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
EP1092779B1 (en) 1999-10-11 2009-11-25 Institut Pasteur Lentiviral vectors for the preparation of immunotherapeutical compositions
DK1224314T3 (da) 1999-10-12 2007-05-21 Inst Nat Sante Rech Med Lentiviralt triplex-DNA samt vektorer og rekombinante celler indeholder lentiviralt triplex-DNA
FR2862648B1 (fr) * 2003-11-21 2006-02-03 Biomerieux Sa Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c
CA2504451A1 (en) * 2004-08-10 2006-02-10 Geron Corporation Dendritic cell vaccines for treating cancer made from embryonic stem cells
EP1748067A1 (en) 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes

Also Published As

Publication number Publication date
ES2440768T3 (es) 2014-01-30
CA2616674A1 (en) 2007-02-08
JP2012183076A (ja) 2012-09-27
EP2626420B1 (en) 2016-06-22
JP2016104031A (ja) 2016-06-09
WO2007014740A2 (en) 2007-02-08
CA2616674C (en) 2018-09-04
EP2626420A3 (en) 2013-10-30
JP2009502150A (ja) 2009-01-29
US20140056932A1 (en) 2014-02-27
WO2007014740A3 (en) 2007-05-03
US8003773B2 (en) 2011-08-23
EP1748067A1 (en) 2007-01-31
US9624479B2 (en) 2017-04-18
DK1910529T3 (da) 2014-01-13
EP1910529A2 (en) 2008-04-16
EP1910529B1 (en) 2013-10-16
US20090175892A1 (en) 2009-07-09
US8858931B2 (en) 2014-10-14
JP5631545B2 (ja) 2014-11-26
EP2626420A2 (en) 2013-08-14
DK2626420T3 (en) 2016-09-26
JP6257667B2 (ja) 2018-01-10
US20100172878A1 (en) 2010-07-08
JP5931812B2 (ja) 2016-06-08
PL2626420T3 (pl) 2017-01-31
ES2590462T3 (es) 2016-11-22
JP2013230164A (ja) 2013-11-14
JP5836202B2 (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
PT2626420T (pt) Polipéptidos que codificam epítopos de terth restritos à molécula hla-b7 da classe i do cph, os seus análogos ou poliepítopos
AP2335A (en) Fungicidal mixtures based on azolopyrimidinylamines.
DK1849470T4 (en) Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor
IL209963A0 (en) Epitope analogues
EG25126A (en) Steam reforming.
AP2281A (en) Novel compounds.
EP1910920A4 (en) CODE TRANSFORMATION
EP1913490A4 (en) CODE PRODUCTION PATTERNS
PL2468732T3 (pl) 1H-Chinazolino-2,4-diony
EP1841430A4 (en) SUBSTITUTED PYRIDAZINYL AND PYRIMIDINYL-CHINOLIN-4-YLAMINE ANALOGUE
EG25121A (en) Steam reforming.
HK1075173A2 (en) Skate.
SI2221383T1 (sl) Nukleotidna sekvenca, ki kodira proti-glivični polipeptid
EP1853274A4 (en) 2-METHYLENE-19-NOR- (20S-24S) -1ALPHA, 25-D HYDROXYVITAMINE-D2
AP2337A (en) Motilide compounds.
IL190538A0 (en) Two-part code
EP1874979A4 (en) REACTOR
EP1723145A4 (en) SUBSTITUTED 5,12-DIAZENZOANTHRACENANALOGA
HK1072153A2 (en) Goal-keeping toy set.
GB0516252D0 (en) The dive daemon
IL185408A0 (en) (+)-and(-)-8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1)oct-2-ene
GB0507105D0 (en) Coding data
HK1063959A2 (en) Picture-projected pen.
GB0504761D0 (en) Alfatie, Coliawel, Omaatie
AU4212P (en) Goldenlighthouse Banksia spinulosa var. collina